Sugar Control

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Sugar Control
Generic name: MORUS ALBA LEAF
Manufacturer: Bispit Canada Ltd.
Product type: HUMAN OTC DRUG
SPL set ID: 3df65e10-1eff-0fda-e063-6294a90af19e
SPL ID: 3df65e10-1f00-0fda-e063-6294a90af19e
Version: 1
Effective date: 2025-09-04
Source export date: 2026-10-27
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/d7629e6f844435cfe6cb0cf8c5341c46775ea16c5af42c77a22a2ffe820a2cd2/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 19:52:16

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Sugar Control	openfda.brand_name
generic name		MORUS ALBA LEAF	openfda.generic_name
manufacturer name		Bispit Canada Ltd.	openfda.manufacturer_name
ndc	package	85631-008-01	openfda.package_ndc
ndc	product	85631-008	openfda.product_ndc
ndc11	package	85631000801	derived:openfda.package_ndc
spl id		3df65e10-1f00-0fda-e063-6294a90af19e	id
spl set id		3df65e10-1eff-0fda-e063-6294a90af19e	set_id
unii		83M15WOS0F	openfda.unii
unii		Z9W8997416	openfda.unii
unii		7BN8468162	openfda.unii
unii		3NY3SM6B8U	openfda.unii
unii		M8YIA49Q2P	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

1. As a chronic metabolic issue, high bloodsugar requires long-term management inconjunction with diet control and a suitableexercise plan. A low-carbohydrate, low-sugardiet is recommended.2. This product is not a substitute formedication.Individuals on long-term medicationshould consult their physician beforediscontinuing any medication and shouldmonitor their daily blood sugar levels.3. This product is not recommended forindividuals with hypoglycemia.4. Keep properly and out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.